Literature DB >> 18296052

Mitochondria in cancer cells: what is so special about them?

Vladimir Gogvadze1, Sten Orrenius, Boris Zhivotovsky.   

Abstract

The past decade has revealed a new role for the mitochondria in cell metabolism--regulation of cell death pathways. Considering that most tumor cells are resistant to apoptosis, one might question whether such resistance is related to the particular properties of mitochondria in cancer cells that are distinct from those of mitochondria in non-malignant cells. This scenario was originally suggested by Otto Warburg, who put forward the hypothesis that a decrease in mitochondrial energy metabolism might lead to development of cancer. This review is devoted to the analysis of mitochondrial function in cancer cells, including the mechanisms underlying the upregulation of glycolysis, and how intervention with cellular bioenergetic pathways might make tumor cells more susceptible to anticancer treatment and induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296052     DOI: 10.1016/j.tcb.2008.01.006

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  190 in total

1.  K-Ras and mitochondria: dangerous liaisons.

Authors:  Jiri Neuzil; Jakub Rohlena; Lan-Feng Dong
Journal:  Cell Res       Date:  2011-09-27       Impact factor: 25.617

2.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

3.  Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L.

Authors:  Qilong Wang; Shengnan Wu; Huaiping Zhu; Ye Ding; Xiaoyan Dai; Changhan Ouyang; Young-Min Han; Zhonglin Xie; Ming-Hui Zou
Journal:  Autophagy       Date:  2017-01-13       Impact factor: 16.016

4.  Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst.

Authors:  Shengnan Wu; Feifan Zhou; Yanchun Wei; Wei R Chen; Qun Chen; Da Xing
Journal:  Antioxid Redox Signal       Date:  2013-10-05       Impact factor: 8.401

Review 5.  Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.

Authors:  Gantumur Battogtokh; Yeon Su Choi; Dong Seop Kang; Sang Jun Park; Min Suk Shim; Kang Moo Huh; Yong-Yeon Cho; Joo Young Lee; Hye Suk Lee; Han Chang Kang
Journal:  Acta Pharm Sin B       Date:  2018-05-18       Impact factor: 11.413

6.  Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.

Authors:  Jin-Quan Wang; Ping-Yu Zhang; Chen Qian; Xiao-Juan Hou; Liang-Nian Ji; Hui Chao
Journal:  J Biol Inorg Chem       Date:  2013-11-28       Impact factor: 3.358

7.  Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.

Authors:  Yao-An Shen; Chia-Yu Wang; Yi-Tao Hsieh; Yann-Jang Chen; Yau-Huei Wei
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival.

Authors:  Geoffrey E Johnson; Vladimir N Ivanov; Tom K Hei
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

9.  Commentary: oxidative stress reconsidered.

Authors:  Regina Brigelius-Flohé
Journal:  Genes Nutr       Date:  2009-07-16       Impact factor: 5.523

10.  Molecular cloning, expression patterns and subcellular localization of porcine TMCO1 gene.

Authors:  Zhisheng Zhang; Delin Mo; Peiqing Cong; Zuyong He; Fei Ling; Anning Li; Yuna Niu; Xiao Zhao; Chunyan Zhou; Yaosheng Chen
Journal:  Mol Biol Rep       Date:  2009-05-16       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.